Risk stratification for coronary bypass surgery in patients with left ventricular dysfunction: analysis of the

M Argenziano1, H M Spotnitz, W Whang

  • 1Department of Surgery, Columbia University College of Physicians and Surgeons, New York, NY, USA. ma66@columbia.edu

Circulation
|November 24, 1999
PubMed

Insights

Symptomatic heart failure and reoperation increase operative mortality in patients undergoing coronary artery bypass grafting (CABG) with ventricular dysfunction. Patients without heart failure symptoms can undergo CABG with lower mortality risks.

Area of Science:

  • Cardiology
  • Cardiac Surgery

Background:

  • Preoperative patient characteristics significantly impact outcomes after coronary artery bypass grafting (CABG).
  • The CABG Patch Trial investigated prophylactic implantable cardioverter-defibrillator insertion in high-risk CABG patients.
  • This study utilized the CABG Patch Trial database to examine the influence of congestive heart failure (CHF) and angina on morbidity and mortality in patients with ventricular dysfunction.

Purpose of the Study:

  • To investigate the impact of symptomatic congestive heart failure (CHF) and angina on morbidity and mortality in patients undergoing coronary artery bypass grafting (CABG) with ventricular dysfunction.
  • To identify predictors of increased operative mortality and prolonged length of stay (LOS) in this patient population.

Main Methods:

  • Analysis of data from 900 randomized patients with ejection fraction ≤35% and abnormal signal-averaged ECG.
  • Utilized single-variable and stepwise multiple logistic regression for mortality and LOS analysis.
  • Graded severity of CHF using NYHA classification and angina using CCS classification.

Main Results:

  • Perioperative mortality was higher in patients with symptomatic heart failure (7.7%) compared to those without (3.5%).
  • Symptomatic heart failure (NYHA class I-IV) and reoperation were significant predictors of increased mortality.
  • History of stroke was associated with a higher rate of perioperative stroke and increased LOS.

Conclusions:

  • Symptomatic heart failure and reoperation are key predictors of increased operative mortality in CABG patients with ventricular dysfunction.
  • Patients without heart failure symptoms may have relatively low mortality despite reduced ejection fraction.
  • Advanced age, history of stroke, and the presence/severity of heart failure significantly prolong LOS.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...